Lexington-Fayette, Kentucky 2021-06-11 11:34:29 –
The FDA said Friday that it could distribute 10 million doses of Johnson & Johnson’s COVID-19 vaccine manufactured at the problematic Baltimore plant, but ordered the disposal of an additional 60 million doses due to possible contamination. It was.
The FDA states that 10 million doses made by Emergent BioSolutions should be distributed with a warning that the company cannot be guaranteed to follow the proper manufacturing process.
Emergent BioSolutions produced both the Johnson & Johnson and AstraZeneca vaccines earlier this year.But the company march One batch of J & J drugs “did not meet quality standards”.
The· New York Times The factory reports that it has confused the ingredients of the AZ and J & J vaccines.
This story is broken and will be updated.